ACROBiosystems announces the launch of its new brand, ComboX, a combination of universal solutions to support biopharmaceutical drug research, development, and manufacturing.
ACROBiosystems is pleased to announce the launch of its new brand, ComboX, a combination of universal solutions to support biopharmaceutical drug research, development, and manufacturing.
To accelerate and support research in of the biopharmaceutical industry, ACROBiosystems aims to provide high-quality and high-performance products. ComboX is a toolbox of essential drug development tools arranged into an easy, one-stop shop for convenience. These products include Fc receptor proteins, universal antibodies, isotype controls, streptavidin series products, cell culture, activation tools, enzymes, ELISA Kits, and many others.
In the future, ACROBiosystems plan to expand ComboX by developing and launching other universal products that facilitate drug research applications to support and help foster a more efficient, creative, and productive drug research environment.
Developing new therapeutic drugs is not an easy task. Finding ways to help ACROBiosystems’ customers is the motivation behind ComboX and its other products.
Ensuring quality is an essential value in the process of drug research and development, starting from key reagents to the final therapeutic drug. All ComboX products are developed under ACROBiosystems' strict quality control system that has been certified and audited, under ISO9001, ISO13485, CNAS, and GMP requirements.
ACROBiosystems ensure that its products excel in product safety, quality, and are cost-effective. Furthermore, ACROBiosystems continuously monitor and improve its quality control system to meet and exceed customer expectations, regulatory requirements, and the overall market environment. Through the ComboX brand, ACROBiosystems seek to provide worry-free, indispensable tools for biopharmaceutical research and development.